Stephen

DE'AARON FOX SIGNS WITH CURRY BRAND

Retrieved on: 
Thursday, October 26, 2023
NYSE, Stephen, Golden State Warriors, Fox, UA, Athlete, Foot, Golden, UAA, Partnership, Sacramento Kings, De'Aaron Fox, Basketball, 2020–21 Sacramento Kings season, Sport

BALTIMORE, Oct. 26, 2023 /PRNewswire/ -- Under Armour, Inc. (NYSE: UA, UAA) announced today that Sacramento Kings Point Guard, De'Aaron Fox, has signed as the first signature athlete with Curry Brand, for a multi-year partnership. Together, De'Aaron, Stephen, and Curry Brand will partner to collaborate and expand Curry Brand's reach across the basketball space and beyond. With a shared respect and a joint passion for making an impact on and off the court, the All-Stars will evolve their relationship from competitors to partners.

Key Points: 
  • Together, De'Aaron, Stephen, and Curry Brand will partner to collaborate and expand Curry Brand's reach across the basketball space and beyond.
  • He has long been a fan of the brand, its mission, and performance solutions, sporting Curry Brand footwear throughout the 2022-23 season.
  • In his new role, De'Aaron will work closely alongside Stephen and Curry Brand to innovate game-changing footwear and apparel, including launching his own signature footwear under Curry Brand in 2024.
  • "I couldn't think of a better athlete and person to join the Curry Brand team," said Stephen Curry, Professional Basketball Player and President of Curry Brand.

Schwarzman Animal Medical Center to Hold Inaugural Veterinary Technician Conference Kicking-off Veterinary Technician Appreciation Week

Retrieved on: 
Tuesday, September 19, 2023
ECC, Specialist, Biological system, Animal Medical Center, Care, LVT, Traumatic brain injury, Veterinary medicine, Management, Postgraduate education, History, IM, MBA, Stephen, Weill Cornell Medical Center, AMC, Continuing education, Anna Maria Janer Anglarill, Patient, PAWS, Internal medicine, RN, VTS, DVM, Conference, Nursing, Neurology

NEW YORK, Sept. 19, 2023 /PRNewswire/ -- The Stephen & Christine Schwarzman Animal Medical Center will present its first ever Veterinary Technician Conference on October 13th, which recognizes the valuable contributions and critical work performed by veterinary technicians as part of AMC's week-long celebration of National Veterinary Technician Week. This free conference is hosted by the Anna-Maria and Stephen Kellen Institute for Postgraduate Education and will be held at the Uris Auditorium at Weill Cornell Medical Center.

Key Points: 
  • Conference Will Feature 4 Hours of Continuing Education, Networking, and a Moving Keynote
    NEW YORK, Sept. 19, 2023 /PRNewswire/ -- The Stephen & Christine Schwarzman Animal Medical Center will present its first ever Veterinary Technician Conference on October 13th, which recognizes the valuable contributions and critical work performed by veterinary technicians as part of AMC's week-long celebration of National Veterinary Technician Week.
  • "Veterinary technicians serve as the patient's advocate, and we look forward to celebrating and recognizing the technician community throughout Veterinary Technician Appreciation Week."
  • "Working at the Schwarzman Animal Medical Center for 22 years has been an amazing journey," said Nancy Patsos, LVT, VTS (ECC), Chief Veterinary Technician at AMC.
  • I am proud to be part of the future of veterinary medicine at the Schwarzman Animal Medical Center, and I invite veterinary technicians to join me at this event."

NYC's Schwarzman Animal Medical Center Appoints Nicole Seligman as Co-Chair of Board of Trustees

Retrieved on: 
Wednesday, September 6, 2023
Intuitive Machines, General counsel, Connolly, Paramount Global, Veterinary medicine, Sony, MBA, Stephen, AMC, The Doe Fund, Trustee, Williams & Connolly, Pet, Chairperson, RN, Management

NEW YORK, Sept. 6, 2023 /PRNewswire/ -- The Stephen & Christine Schwarzman Animal Medical Center (AMC), the world's largest non-profit animal hospital, is proud to announce the appointment of Nicole Seligman as Co-Chair of the organization's Board of Trustees. She joins current Board Chair Robert Liberman in the role after serving the organization as Vice Chair.

Key Points: 
  • NEW YORK, Sept. 6, 2023 /PRNewswire/ -- The Stephen & Christine Schwarzman Animal Medical Center (AMC), the world's largest non-profit animal hospital, is proud to announce the appointment of Nicole Seligman as Co-Chair of the organization's Board of Trustees.
  • Ms. Seligman brings over four decades of distinguished legal, business, and non-profit experience to AMC.
  • "Nicole has been an incredible resource as Vice Chair of our Board, and I'm honored to welcome her as Co-Chair.
  • There is no better place for pets, and I'm exceedingly proud to serve as Co-Chair of the Board."

MAPS Receives $5 Million Grant from the Steven & Alexandra Cohen Foundation

Retrieved on: 
Thursday, June 22, 2023
Insurance, Depression, Anxiety, New Drug Application, Multidisciplinary Association for Psychedelic Studies, Quality of life, Research, Stephen, Veteran, MAPS, Patient, SAN, Addiction, FDA, PTSD, Safety, Pharmaceutical industry

SAN JOSE, Calif., June 22, 2023 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced that the Steven & Alexandra Cohen Foundation has awarded MAPS a $5 million grant.

Key Points: 
  • SAN JOSE, Calif., June 22, 2023 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced that the Steven & Alexandra Cohen Foundation has awarded MAPS a $5 million grant.
  • MAPS Public Benefit Corporation (MAPS PBC), a MAPS subsidiary, plans to submit the New Drug Application for MDMA-assisted therapy for PTSD to the FDA later this year.
  • The Steven & Alexandra Cohen Foundation and MAPS have a shared commitment to ensuring there is equitable access to MDMA- and other psychedelic-assisted therapies.
  • Since 2020, the Steven & Alexandra Cohen Foundation has committed over $10 million of philanthropic support to MAPS’ mission, including MAPS-sponsored clinical research of MDMA- assisted therapy.

The Emma and Georgina Bloomberg AMC to the Rescue Fund Celebrates 10th Anniversary

Retrieved on: 
Tuesday, March 21, 2023
Shabba, Oncology, Scholar Rescue Fund, Animal Medical Center, American Pit Bull Terrier, Veterinarian, MBA, Stephen, AMC, Animal, Emma, Pet, RN, Health, DVM, Family, Pharmaceutical industry, Asset management, Rescue

NEW YORK, March 21, 2023 /PRNewswire/ -- In 2023 the Stephen & Christine Schwarzman Animal Medical Center celebrates the 10th Anniversary of the Emma and Georgina Bloomberg AMC to the Rescue Fund. Established in February 2013, the fund provides free or subsidized specialty care to rescue animals whose health is an obstacle to their adoption. Over the last decade the fund has helped over 600 pets, partnered with over 140 rescue groups, and provided over $1.6 million in donated care to help animals find their forever home.

Key Points: 
  • NEW YORK, March 21, 2023 /PRNewswire/ -- In 2023 the Stephen & Christine Schwarzman Animal Medical Center celebrates the 10th Anniversary of the Emma and Georgina Bloomberg AMC to the Rescue Fund.
  • "The 10th anniversary of AMC to the Rescue is an opportunity for us to recognize the great care and support this program receives from not only the wonderful rescue groups in our communities, but also from our amazing AMC teams.
  • The fund was named The Emma and Georgina Bloomberg AMC to the Rescue Fund in 2020 in recognition of their generous support.
  • AMC will highlight several heartwarming stories of rescue animals that have been helped by the fund throughout the year.

National Lyme Clinical Trials Network Gains Its First West Coast Center, Thanks to $1M+ Donation from Bay Area Lyme Foundation

Retrieved on: 
Thursday, March 9, 2023
Linda, University of California, San Francisco Fetal Treatment Center, University, Johns Hopkins University, San Francisco, Network, Diagnosis, Publishing, Columbia University, Stephen, Research, Patient, UCSF, Growth, Bacteria, Bangladesh Technical Education Board, Lyme disease, Doctor of Philosophy, MD, Hope, Pharmaceutical industry

This new center will become the first West Coast site of the Lyme Clinical Trials Network .

Key Points: 
  • This new center will become the first West Coast site of the Lyme Clinical Trials Network .
  • “The founding of the UCSF Lyme Clinical Trials Center provides a unique opportunity for Lyme patients to participate in the next generation of therapeutic trials to combat this devastating disease,” said Charles Chiu, MD, PhD, of the University of California San Francisco who will lead the UCSF Lyme Clinical Trials Center.
  • “The Lyme Clinical Trials Network was created to help bring treatments and hope to Lyme disease patients and their families,” said Alexandra Cohen, president of the Steven & Alexandra Cohen Foundation.
  • His team will be evaluating and treating patients for case registry and pilot studies, and publishing in conjunction with other Lyme Clinical Trials Network sites.

Schwarzman Animal Medical Center Appoints Helen Irving, RN, MBA, President and Chief Executive Officer

Retrieved on: 
Wednesday, January 25, 2023
Fairleigh Dickinson University, National Cancer Center, United Kingdom, Health, MBA, Health administration, AMC, Hospital, RN, NewYork-Presbyterian Hospital, Pet, NYIT, Stephen, Organization, Mount Sinai Medical Center, Family, Trustee, Nursing, Tobacco

NEW YORK, Jan. 25, 2023 /PRNewswire/ -- The Stephen & Christine Schwarzman Animal Medical Center Board of Trustees has announced Helen Irving, RN, MBA, as its incoming President and Chief Executive Officer. Ms. Irving joins AMC, the largest non-profit animal hospital in the world, on January 30, 2023, during a pivotal time for the 113-year-old Upper East Side institution. The hospital is currently undergoing a $100 Million expansion and modernization project to accommodate unprecedented demand for its veterinary care. 

Key Points: 
  • The Seasoned Healthcare Executive Brings 30+ Years of Clinical, Administrative, and Operations Experience
    NEW YORK, Jan. 25, 2023 /PRNewswire/ -- The Stephen & Christine Schwarzman Animal Medical Center Board of Trustees has announced Helen Irving, RN, MBA, as its incoming President and Chief Executive Officer.
  • The hospital is currently undergoing a $100 Million expansion and modernization project to accommodate unprecedented demand for its veterinary care.
  • An accomplished leader and healthcare executive, Helen Irving has devoted her 30-year career to operational excellence in the delivery of healthcare services.
  • "Leading the Schwarzman Animal Medical Center is such an exciting opportunity given my deep roots in New York's healthcare system," said Ms. Irving.

T2 Biosystems Advances to the Phase 2 in HHS and the Steven and Alexandra Cohen Foundation’s LymeX Diagnostics Prize

Retrieved on: 
Monday, February 6, 2023
HHS, Antibody, Panel, Infection, Food, Diagnosis, Human, Office of Inspector General, U.S. Department of Health and Human Services, Patent, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, FDA, Food and Drug Administration, Biology, Bacteria, Borrelia burgdorferi, Stephen, Pharmaceutical industry, Vaccine, Lyme disease

The goal of the multiphase LymeX Innovation Accelerator (LymeX) prize competition is to nurture the development of diagnostics toward Food and Drug Administration (FDA) review.

Key Points: 
  • The goal of the multiphase LymeX Innovation Accelerator (LymeX) prize competition is to nurture the development of diagnostics toward Food and Drug Administration (FDA) review.
  • Based on the judges’ evaluations, the panel will recommend up to five Phase 2 winners of the LymeX Diagnostics Prize.
  • Thanks to a $10 million pledge to the LymeX Diagnostics Prize from the Steven & Alexandra Cohen Foundation, $9 million in LymeX prizes are projected to be available in proposed future phases.
  • Phase 2 is part of this multi-year, multi-phased LymeX Diagnostics Prize series that HHS plans to announce further details for in early 2023.

Schwarzman Animal Medical Center Achieves $100 Million Capital Campaign Fundraising Goal

Retrieved on: 
Wednesday, January 18, 2023
Animal, Gift, Chairperson, Campaign, Stephen, Research, Pittsburgh Crawfords, Medicine, AMC, Denise, Pharmaceutical industry, Chris

NEW YORK, Jan. 18, 2023 /PRNewswire/ -- The Stephen & Christine Schwarzman Animal Medical Center, the largest non-profit animal hospital in the world, announced today that it has successfully met its $100 million Gift of Love Capital Campaign goal. The Campaign was launched in 2019 to fund a transformational center-wide expansion and modernization project, with construction breaking ground in 2021. 

Key Points: 
  • NEW YORK, Jan. 18, 2023 /PRNewswire/ -- The Stephen & Christine Schwarzman Animal Medical Center, the largest non-profit animal hospital in the world, announced today that it has successfully met its $100 million Gift of Love Capital Campaign goal.
  • "Our deep appreciation and thanks go to our many generous benefactors, who understood the need to expand and modernize our facility and responded to the challenge," said Robert Liberman, Board Chair, Schwarzman Animal Medical Center.
  • The Campaign goal was reached with a final $5 million gift from Chris and Trustee Bruce Crawford, bringing their total campaign contribution to $10 million.
  • "We have supported the Schwarzman Animal Medical Center for many years because of the unparalleled care provided to animals," said Chris and Bruce Crawford.

HHS and the Cohen Foundation Name T2 Biosystems a Phase 1 Winner in LymeX Diagnostics Prize

Retrieved on: 
Monday, November 7, 2022
Infection, Private Securities Litigation Reform Act, FDA, Failure, U.S. Securities and Exchange Commission, Rash, Office of Inspector General, U.S. Department of Health and Human Services, Fever, Patent, Ixodes, Stephen, SEC, Solution, Panel, Erythema migrans, Food, GLOBE, Tick, CEO, Genetically modified bacteria, LDT, Diagnosis, Patient, Leadership, Fatigue, Ixodes pacificus, Heart, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Contract, Human, Borrelia burgdorferi, COVID-19, Microfluidics, Adoption, Bacteria, HHS, Headache, Joint, CDC, Nervous system, Antibody, Pacific coast, Health, BioSystems, NASDAQ, Pharmaceutical industry, Vaccine, Medical imaging, Lyme disease

LEXINGTON, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation (Cohen Foundation) have selected T2 Biosystems as a Phase 1 winner in the LymeX Diagnostics Prize, a LymeX Innovation Accelerator (LymeX) prize competition to accelerate the development of Lyme disease diagnostics.

Key Points: 
  • LEXINGTON, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation (Cohen Foundation) have selected T2 Biosystems as a Phase 1 winner in the LymeX Diagnostics Prize, a LymeX Innovation Accelerator (LymeX) prize competition to accelerate the development of Lyme disease diagnostics.
  • As a Phase 1 winner, T2 Biosystems will receive $100,000 and an invitation to participate in a second phase.
  • At the discretion of HHS and the Cohen Foundation, and subject to availability of future funding, at least one additional phase may follow Phase 2.
  • Thanks to a $10 million pledge to the LymeX Diagnostics Prize from the Cohen Foundation, $9 million in additional LymeX prizes are projected to be available in proposed future phases.